Study #PA12-0668
Tracking of long-term T-cell responses in metastatic melanoma patients having received autologous tumor-infiltrating lymphocyte (TIL) adoptive cell therapy, or who have progressed following TIL adoptive cell therapy and are being treated with additional i
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Tracking T-cell responses in metastatic melanoma patients having received autologous tumor-infiltrating lymphocyte (TIL) adoptive cell therapy
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Melanoma, Skin
Study phase:
Not applicable
Physician name:
Cara Haymaker
Department:
Melanoma Medical Oncology
For general questions about clinical trials:
1-844-737-0154
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.